Skin cancer is the most common neoplasm in the United States with a lifetime risk equal to that of all other cancers combined. Like other cancers, skin cancers arise via the accumulative acquisition of discrete cooperating genetic events. The purpose of this proposal is to dissect the molecular mechanisms that mediate the roles of oncogenes and tumor suppressor genes in skin carcinogenesis. Based on previous studies and new preliminary data, the following is proposed: 1) Missense mutations in the p53 tumor suppressor gene, such as p53R172H (equivalent to the human p53R172H """"""""hot spot"""""""" mutation), exhibit a gain-of-function activity resulting in an increased susceptibility to skin cancer and accelerated tumor progression. 2) Centrosome amplification induced by elevated levels of Aurora-2 kinase contributes to the accelerated tumor progression observed in mice expressing a p53R172H allele in the epidermis. 3) Deregulated expression of the p53 homologue, p63, promotes skin carcinogenesis through its ability to induce proliferation and inhibit terminal differentiation. 4) Deregulated expression of c-Myc influences both tumor susceptibility and tumor phenotype by inducing proliferation of stem cells and by altering their cell fate, and deregulated expression of bcl-xL, an inhibitor of apoptosis, may further augment the oncogenic effect of c-Myc. These hypotheses will be tested using inducible mouse models that allow the activation of oncogenes or the inactivation of tumor suppressor genes in a restricted area of the skin in stem cells that renew the epidermis and its appendages. This approach allows the generation of mice with genetic changes that closely mimic the sporadic focal accumulation of somatic mutations in human tumors. The tumors that develop in these inducible mouse models will be a valuable resource, since they arise as a result of discrete genetic events and progress to metastases by mechanisms that are dependent on and independent of genetic instability. Thus, these tumors will be analyzed with Affymetrix and BAC/CGH arrays to identify novel genetic changes associated with tumor progression. The development of transgenic/knockout mouse models with defined genetic alterations, which have been implicated in causing human skin cancer, will have a major impact on the development of novel therapeutic approaches in the future.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research Project (R01)
Project #
2R01CA052607-14
Application #
6822730
Study Section
Cancer Etiology Study Section (CE)
Program Officer
Okano, Paul
Project Start
1990-08-01
Project End
2009-06-30
Budget Start
2004-09-02
Budget End
2005-06-30
Support Year
14
Fiscal Year
2004
Total Cost
$473,219
Indirect Cost
Name
Baylor College of Medicine
Department
Anatomy/Cell Biology
Type
Schools of Medicine
DUNS #
051113330
City
Houston
State
TX
Country
United States
Zip Code
77030
Yang, N; Leung, E L-H; Liu, C et al. (2017) INTU is essential for oncogenic Hh signaling through regulating primary cilia formation in basal cell carcinoma. Oncogene 36:4997-5005
Lee, Sangjun; Rodriguez-Villanueva, Julio; McDonnell, Timothy (2017) Restrained Terminal Differentiation and Sustained Stemness in Neonatal Skin by Ha-Ras and Bcl-2. Am J Dermatopathol 39:199-203
Liu, Ying; Snedecor, Elizabeth R; Zhang, Xu et al. (2016) Correction of Hair Shaft Defects through Allele-Specific Silencing of Mutant Krt75. J Invest Dermatol 136:45-51
Riemondy, Kent; Wang, Xiao-jing; Torchia, Enrique C et al. (2015) MicroRNA-203 represses selection and expansion of oncogenic Hras transformed tumor initiating cells. Elife 4:
Torchia, Enrique C; Zhang, Lei; Huebner, Aaron J et al. (2013) Aurora kinase-A deficiency during skin development impairs cell division and stratification. J Invest Dermatol 133:78-86
White, Ruth A; Neiman, Jill M; Reddi, Anand et al. (2013) Epithelial stem cell mutations that promote squamous cell carcinoma metastasis. J Clin Invest 123:4390-404
Torchia, E C; Caulin, C; Acin, S et al. (2012) Myc, Aurora Kinase A, and mutant p53(R172H) co-operate in a mouse model of metastatic skin carcinoma. Oncogene 31:2680-90
Chen, Jiang; Roop, Dennis R (2012) Mimicking hair disorders by genetic manipulation of organ-cultured human hair follicles. J Invest Dermatol 132:2312-2314
Terzian, Tamara; Dumble, Melissa; Arbab, Farinaz et al. (2011) Rpl27a mutation in the sooty foot ataxia mouse phenocopies high p53 mouse models. J Pathol 224:540-52
Honeycutt, Kimberly A; Waikel, Rebekah L; Koster, Maranke I et al. (2010) The effect of c-myc on stem cell fate influences skin tumor phenotype. Mol Carcinog 49:315-9

Showing the most recent 10 out of 58 publications